Modeling of 82 brand drugs with ≥$100 million Medicaid spend found net prices exceeded at least one international reference ...

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...

Terms & Conditions Terms & Conditions This Statement was last revised [01/16/2026] TERMS AND CONDITIONS OF USE PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF USE (THE “TERMS”) CAREFULLY BEFORE ...

The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...

Evidence-Based Oncology ™ is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

Our family of journals—The American Journal of Managed Care®, Population Health, Equity & Outcomes, and Evidence-Based Oncology™—is seeking to publish timely research and commentary. Find the right ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

This study examines how key players in managed care drive postacute home health referrals, identifying tensions, limited ...

Minnesota’s $515 million quarterly withholding and subsequent $1.3 billion deferral signal a more punitive federal stance that could normalize aggressive liquidity controls over state Medicaid ...

Propensity-matched comparisons across 11 Kaiser Permanente Southern California service areas showed similar 30-day composite ...